CellSource Co.,Ltd.

Cellsource (4880) is a company listed on the Japanese market that develops various products and services. In terms of company profile, CellSource Co., Ltd. is a biotech startup headquartered in Shibuya-ku, Tokyo. Developing regenerative medicine related business. For medical institutions, we provide contract processing services for adipose-derived stem cells, synovium-derived stem cells, blood, etc., as well as consulting services that support related legal compliance and business management. The current main business areas are orthopedics (osteoarthritis, sports injuries, etc.), plastic surgery (breast reconstruction), and obstetrics and gynecology (infertility treatment), with over 1,800 affiliated medical institutions. When understanding the company's business content, it is easier to get a complete picture by looking at the company's main products and services, sales channels, customer base, and domestic and overseas expansion status. In addition to the stability of existing businesses, publicly available company information also provides clues to understanding a company's business, including new products and service expansion, overseas expansion, capital investment, and trends in alliances and M&A. The Company's revenues may be affected by economic trends, foreign exchange rates, raw material prices, the regulatory environment, technological changes, and the demands of its major customers and markets. When reading an overview on a financial website, check the latest financial statements, securities reports, timely disclosure, and company plans in addition to the explanatory text to more accurately track changes in the business.